IEEPA Tariff Refunds Are Coming: What Medtech Needs to Know
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
Supply Chain
Learn more about our Supply Chain work.
Navigating the ACCESS & TEMPO Models: A Direct Dialogue with CMMI & FDA Leaders
Watch AdvaMed’s® exclusive member-only webinar featuring a direct dialogue with CMS Innovation Center leadership on the newly released ACCESS & TEMPO Model. Attendees will gain critical insights into model performance…
The Supreme Court Struck Down IEEPA Tariffs – What Medtech Needs To Know
The U.S. Supreme Court recently marked a significant shift in the tariff landscape, learn what that means for your organization.
AdvaMed® Supports United States-Mexico-Canada Agreement Renewal
WASHINGTON—AdvaMed, the MedTech Association®, representing more than 650 medtech and health tech companies, the majority small businesses, today expressed support for renewal of the United States-Mexico-Canada Agreement (USMCA). Scott Whitaker,AdvaMed®…
AdvaMed® Calls U.S.-China Trade Announcement a “Positive Step” for U.S.-led Medtech
WASHINGTON—AdvaMed, the MedTech Association®, called the U.S.-China trade announcement a positive step toward supporting the U.S.-led medtech industry and its service to patients nationwide and globally.
AdvaMed® Responds to Commerce Department Section 232 National Security Investigation, Seeks Policies to Strengthen U.S. Position as Global Medtech Leader
WASHINGTON—AdvaMed, the MedTech Association®, today submitted formal comments responding to the U.S. Department of Commerce investigation into whether the U.S.’s current level of medtech imports has national security implications. The…
AdvaMed® Statement on Commerce Department Section 232 National Security Investigation
WASHINGTON—AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker on the Administration’s announcement of its investigation under Section 232 of the Trade Expansion Act into…
The Kennedy v Braidwood Ruling: What’s Next for MedTech
JoinAdvaMed® and Reed Smith experts to explore how the Supreme Court’s ACA ruling in Braidwood could shape preventive care and MedTech policy.
Supreme Court’s Decision in Kennedy v. Braidwood Management, Inc.
Explore the impact of the Supreme Court’s decision in Kennedy v. Braidwood on the ACA preventive services mandate and its implications for MedTech policy.
URGENT: Court Ruling on Tariffs — Implications for Medtech
Emergency Briefing on Court Ruling on Tariffs and Its Impact on Medtech. Now On Demand!